Normal view MARC view ISBD view

In vitro and in silico antioxidant and toxicological activities of Achyrocline satureioides. [electronic resource]

By:

Salgueiro, Andréia C F

Contributor(s):

Producer: 20170421Description: 6-14 p. digitalISSN:

1872-7573

Subject(s):

Online resources:

Available from publisher's website

In: Journal of ethnopharmacology vol. 194

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

21 Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer Tumors Greater Than 5 cm: Safety and Efficacy.
by Woody, Neil M
22 Lung stereotactic body radiation therapy: regional nodal failure is not predicted by tumor size.
by Marwaha, Gaurav
23 Synchronous non small cell lung cancer nodules treated with stereotactic body radiation therapy (SBRT).
by Kumar, Aryavarta M S
24 Shifting from hypofractionated to "conventionally" fractionated thoracic radiotherapy: a single institution's 10-year experience in the management of limited-stage small-cell lung cancer using concurrent chemoradiation.
by Videtic, Gregory M M
25 Stereotactic Body Radiotherapy for T3N0 Lung Cancer With Chest Wall Invasion.
by Berriochoa, Camille
26 Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control.
by Videtic, Gregory M M
27 Predicting chest wall pain from lung stereotactic body radiotherapy for different fractionation schemes.
by Woody, Neil M
28 Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT).
by Stephans, Kevin L
29 Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.
by Burdick, Michael J
30 Effect of Tumor Location and Dosimetric Predictors for Chest Wall Toxicity in Single-Fraction Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
by Manyam, Bindu V
31 Severe local toxicity after lung stereotactic body radiation therapy: lesional abscess leading to bronchocutaneous fistula requiring surgical marsupialization.
by Woody, Neil M
32 Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: non-small-Cell lung cancer (NSCLC).
by Belderbos, José S A
33 Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: small-cell lung cancer (SCLC).
by Videtic, Gregory M M
34 Elective nodal irradiation (ENI) in locally advanced non-small-cell lung cancer (NSCLC): evidence versus opinion?
by Belderbos, José S A
35 30 Gy or 34 Gy? Comparing 2 single-fraction SBRT dose schedules for stage I medically inoperable non-small cell lung cancer.
by Videtic, Gregory M M
36 Stereotactic body radiation therapy-based treatment model for stage I medically inoperable small cell lung cancer.
by Videtic, Gregory M M
37 Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases.
by Guo, Susan
38 Local control for clinical stage I non-small cell lung cancer treated with 5-fraction stereotactic body radiation therapy is not associated with treatment schedule.
by Samson, Pamela
39 Comprehensive analysis of pulmonary function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients.
by Stephans, Kevin L
40 Impaired diffusion capacity predicts for decreased treatment tolerance and survival in limited stage small cell lung cancer patients treated with concurrent chemoradiation.
by Videtic, Gregory M M